ArticleFrontiers in immunology2025

Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.

Wuyuan Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.